EDN1 and glaucoma: In this context, inhibition of astrocyte activation has been shown to increase neuronal survival in experimental glaucoma models via modulation of a tyrosine kinase inhibitor of epidermal growth factor receptor (200) or blocking of endothelin-1 (201).